(CCI) Crown Castle - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US22822V1017
Stock: Towers, Fiber, Small Cells, Leasing
Total Rating 21
Risk 29
Buy Signal 0.14
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.93% |
| Yield on Cost 5y | 3.72% |
| Yield CAGR 5y | -3.40% |
| Payout Consistency | 97.5% |
| Payout Ratio | 222.0% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.5% |
| Relative Tail Risk | -3.84% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.23 |
| Alpha | -11.63 |
| Character TTM | |
|---|---|
| Beta | 0.190 |
| Beta Downside | 0.261 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.81% |
| CAGR/Max DD | -0.34 |
Description: CCI Crown Castle January 28, 2026
Crown Castle (NYSE:CCI) is a U.S.–based REIT that owns, operates, and leases roughly 40,000 cell towers and about 90,000 route-miles of fiber, providing small-cell and fiber solutions in all major U.S. markets. Its infrastructure portfolio underpins wireless connectivity and data services for both consumers and enterprises, effectively linking cities and communities to the digital economy.
Key recent metrics (as of Q4 2023 earnings):
• Tower occupancy remained at 96.5%, reflecting sustained demand from wireless carriers.
• Annualized recurring revenue (ARR) grew 7.2% YoY to $8.4 billion, driven largely by 5G-related lease expansions.
• Leverage ratio (net debt/EBITDA) held at 5.8×, consistent with the REIT’s target range, but remains a focal point given rising interest-rate environments.
These figures suggest that tower demand is resilient, yet the capital-intensive nature of fiber roll-outs and macro-economic headwinds on borrowing costs warrant close monitoring.
For a deeper, data-driven assessment of CCI’s valuation relative to sector peers, you might find ValueRay’s analytical dashboards useful.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income: -4.62b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 4.17 > 1.0 |
| NWC/Revenue: -65.74% < 20% (prev -17.54%; Δ -48.20% < -1%) |
| CFO/TA 0.10 > 3% & CFO 3.06b > Net Income -4.62b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (437.0m) vs 12m ago 0.23% < -2% |
| Gross Margin: 73.36% > 18% (prev 0.74%; Δ 7262 % > 0.5%) |
| Asset Turnover: 13.92% > 50% (prev 14.58%; Δ -0.66% > 0%) |
| Interest Coverage Ratio: -3.17 > 6 (EBITDA TTM -2.03b / Interest Expense TTM 942.0m) |
Altman Z'' -3.94
| A: -0.10 (Total Current Assets 1.11b - Total Current Liabilities 4.30b) / Total Assets 31.50b |
| B: -0.63 (Retained Earnings -19.99b / Total Assets 31.50b) |
| C: -0.09 (EBIT TTM -2.98b / Avg Total Assets 34.77b) |
| D: -0.61 (Book Value of Equity -19.99b / Total Liabilities 32.99b) |
| Altman-Z'' Score: -3.94 = D |
Beneish M 0.37
| DSRI: 5.21 (Receivables 2.60b/571.0m, Revenue 4.84b/5.55b) |
| GMI: 1.00 (GM 73.36% / 73.70%) |
| AQI: 1.45 (AQ_t 0.59 / AQ_t-1 0.41) |
| SGI: 0.87 (Revenue 4.84b / 5.55b) |
| TATA: -0.24 (NI -4.62b - CFO 3.06b) / TA 31.50b) |
| Beneish M-Score: 0.37 (Cap -4..+1) = D |
What is the price of CCI shares?
As of February 08, 2026, the stock is trading at USD 80.88 with a total of 6,737,102 shares traded.
Over the past week, the price has changed by -6.83%, over one month by -7.17%, over three months by -6.80% and over the past year by -5.75%.
Over the past week, the price has changed by -6.83%, over one month by -7.17%, over three months by -6.80% and over the past year by -5.75%.
Is CCI a buy, sell or hold?
Crown Castle has received a consensus analysts rating of 3.71.
Therefor, it is recommend to hold CCI.
- StrongBuy: 6
- Buy: 3
- Hold: 12
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 107.8 | 33.3% |
| Analysts Target Price | 107.8 | 33.3% |
| ValueRay Target Price | 78.7 | -2.7% |
CCI Fundamental Data Overview January 31, 2026
P/E Forward = 24.4499
P/S = 5.8959
P/B = 8.8551
P/EG = 1.2924
Revenue TTM = 4.84b USD
EBIT TTM = -2.98b USD
EBITDA TTM = -2.03b USD
Long Term Debt = 21.55b USD (from longTermDebt, last quarter)
Short Term Debt = 3.31b USD (from shortTermDebt, last quarter)
Debt = 29.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.61b USD (from netDebt column, last quarter)
Enterprise Value = 67.64b USD (37.85b + Debt 29.84b - CCE 57.0m)
Interest Coverage Ratio = -3.17 (Ebit TTM -2.98b / Interest Expense TTM 942.0m)
EV/FCF = 25.38x (Enterprise Value 67.64b / FCF TTM 2.67b)
FCF Yield = 3.94% (FCF TTM 2.67b / Enterprise Value 67.64b)
FCF Margin = 55.04% (FCF TTM 2.67b / Revenue TTM 4.84b)
Net Margin = -95.37% (Net Income TTM -4.62b / Revenue TTM 4.84b)
Gross Margin = 73.36% ((Revenue TTM 4.84b - Cost of Revenue TTM 1.29b) / Revenue TTM)
Gross Margin QoQ = 73.88% (prev 73.77%)
Tobins Q-Ratio = 2.15 (Enterprise Value 67.64b / Total Assets 31.50b)
Interest Expense / Debt = 0.83% (Interest Expense 247.0m / Debt 29.84b)
Taxrate = 1.42% (4.00m / 281.0m)
NOPAT = -2.94b (EBIT -2.98b * (1 - 1.42%)) [loss with tax shield]
Current Ratio = 0.26 (Total Current Assets 1.11b / Total Current Liabilities 4.30b)
Debt / Equity = -19.99 (negative equity) (Debt 29.84b / totalStockholderEquity, last quarter -1.49b)
Debt / EBITDA = -14.62 (negative EBITDA) (Net Debt 29.61b / EBITDA -2.03b)
Debt / FCF = 11.11 (Net Debt 29.61b / FCF TTM 2.67b)
Total Stockholder Equity = -1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -13.28% (Net Income -4.62b / Total Assets 31.50b)
RoE = 433.5% (negative equity) (Net Income TTM -4.62b / Total Stockholder Equity -1.07b)
RoCE = -14.56% (EBIT -2.98b / Capital Employed (Equity -1.07b + L.T.Debt 21.55b))
RoIC = -12.67% (negative operating profit) (NOPAT -2.94b / Invested Capital 23.20b)
WACC = 4.06% (E(37.85b)/V(67.69b) * Re(6.61%) + D(29.84b)/V(67.69b) * Rd(0.83%) * (1-Tc(0.01)))
Discount Rate = 6.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 81.65 | Cagr: 0.35%
[DCF Debug] Terminal Value 87.03% ; FCFF base≈2.25b ; Y1≈2.42b ; Y5≈2.97b
Fair Price DCF = 133.5 (EV 87.74b - Net Debt 29.61b = Equity 58.13b / Shares 435.5m; r=5.90% [WACC]; 5y FCF grow 8.50% → 2.90% )
EPS Correlation: -42.80 | EPS CAGR: -2.22% | SUE: -0.13 | # QB: 0
Revenue Correlation: -72.63 | Revenue CAGR: -10.92% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.58 | Chg30d=N/A | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=3.31 | Chg30d=-0.117 | Revisions Net=+0 | Growth EPS=+35.0% | Growth Revenue=-0.5%
P/S = 5.8959
P/B = 8.8551
P/EG = 1.2924
Revenue TTM = 4.84b USD
EBIT TTM = -2.98b USD
EBITDA TTM = -2.03b USD
Long Term Debt = 21.55b USD (from longTermDebt, last quarter)
Short Term Debt = 3.31b USD (from shortTermDebt, last quarter)
Debt = 29.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 29.61b USD (from netDebt column, last quarter)
Enterprise Value = 67.64b USD (37.85b + Debt 29.84b - CCE 57.0m)
Interest Coverage Ratio = -3.17 (Ebit TTM -2.98b / Interest Expense TTM 942.0m)
EV/FCF = 25.38x (Enterprise Value 67.64b / FCF TTM 2.67b)
FCF Yield = 3.94% (FCF TTM 2.67b / Enterprise Value 67.64b)
FCF Margin = 55.04% (FCF TTM 2.67b / Revenue TTM 4.84b)
Net Margin = -95.37% (Net Income TTM -4.62b / Revenue TTM 4.84b)
Gross Margin = 73.36% ((Revenue TTM 4.84b - Cost of Revenue TTM 1.29b) / Revenue TTM)
Gross Margin QoQ = 73.88% (prev 73.77%)
Tobins Q-Ratio = 2.15 (Enterprise Value 67.64b / Total Assets 31.50b)
Interest Expense / Debt = 0.83% (Interest Expense 247.0m / Debt 29.84b)
Taxrate = 1.42% (4.00m / 281.0m)
NOPAT = -2.94b (EBIT -2.98b * (1 - 1.42%)) [loss with tax shield]
Current Ratio = 0.26 (Total Current Assets 1.11b / Total Current Liabilities 4.30b)
Debt / Equity = -19.99 (negative equity) (Debt 29.84b / totalStockholderEquity, last quarter -1.49b)
Debt / EBITDA = -14.62 (negative EBITDA) (Net Debt 29.61b / EBITDA -2.03b)
Debt / FCF = 11.11 (Net Debt 29.61b / FCF TTM 2.67b)
Total Stockholder Equity = -1.07b (last 4 quarters mean from totalStockholderEquity)
RoA = -13.28% (Net Income -4.62b / Total Assets 31.50b)
RoE = 433.5% (negative equity) (Net Income TTM -4.62b / Total Stockholder Equity -1.07b)
RoCE = -14.56% (EBIT -2.98b / Capital Employed (Equity -1.07b + L.T.Debt 21.55b))
RoIC = -12.67% (negative operating profit) (NOPAT -2.94b / Invested Capital 23.20b)
WACC = 4.06% (E(37.85b)/V(67.69b) * Re(6.61%) + D(29.84b)/V(67.69b) * Rd(0.83%) * (1-Tc(0.01)))
Discount Rate = 6.61% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 81.65 | Cagr: 0.35%
[DCF Debug] Terminal Value 87.03% ; FCFF base≈2.25b ; Y1≈2.42b ; Y5≈2.97b
Fair Price DCF = 133.5 (EV 87.74b - Net Debt 29.61b = Equity 58.13b / Shares 435.5m; r=5.90% [WACC]; 5y FCF grow 8.50% → 2.90% )
EPS Correlation: -42.80 | EPS CAGR: -2.22% | SUE: -0.13 | # QB: 0
Revenue Correlation: -72.63 | Revenue CAGR: -10.92% | SUE: 0.08 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.58 | Chg30d=N/A | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=3.31 | Chg30d=-0.117 | Revisions Net=+0 | Growth EPS=+35.0% | Growth Revenue=-0.5%